Articles by Daniel Marsh
Rolls-Royce Deepens Polish Defense Partnership Amid European Arms Surge
Rolls-Royce has entered a preliminary agreement with Poland's state-backed defense group PGZ to broaden collaboration on propulsion systems for military land and sea platforms. The move aligns with a significant increase in European arms imports and Poland's push to access EU military funding.
BlackRock Fund Limits Spark Liquidity Fears as Private Credit Defaults Hit Record
BlackRock has restricted redemptions from its $26 billion private-credit fund after requests surged, intensifying stress in real estate-linked markets. Fitch warns of record defaults in the sector.
Pfizer's Eczema Candidate Tilrekimig Advances, Eyes Dupixent Rivalry
Pfizer announced its experimental eczema drug tilrekimig achieved its main goal in a mid-stage study, showing significant symptom improvement. The company plans to initiate a pivotal Phase 3 trial later this year.
U.S. Art Auction Sales Surge 23% in 2025, Led by Established Artists
U.S. art auction sales at top houses rose 23% to $3.17 billion in 2025, the first annual gain since 2022, according to Bank of America. The rebound was fueled by historical artists and a focus on quality.
FTSE 100 Recovers from Sharp Drop as Oil Price Spike Roils London
London's FTSE 100 pared steep early losses to close 0.3% lower on Monday, while the FTSE 250 fell 1.6%. A dramatic spike in oil prices above $119 a barrel, driven by Middle East conflict, triggered a broad market sell-off and renewed stagflation fears.
Lumentum Surges on S&P 500 Inclusion, Fueled by Nvidia AI Partnership
Lumentum Holdings shares rallied over 10% on news of its upcoming inclusion in the S&P 500 index, extending gains driven by a major strategic partnership with Nvidia focused on AI photonics.
Stocks Sink as Oil Surge and Jobs Data Fuel Stagflation Worries
U.S. stocks dropped sharply Monday as oil prices neared $120 per barrel and a surprise loss of 92,000 jobs in February intensified concerns about stagflation. The Dow, S&P 500, and Nasdaq each fell roughly 1.3%.
Jefferies Faces Legal Battle, Limits MFS Losses Under $20M
Jefferies Financial Group disclosed that losses from the collapse of UK lender Market Financial Solutions will likely remain below $20 million. The firm also contested a $126.4 million claim from Western Alliance Bancorporation, sparking a legal dispute.
Wealth Managers Boost QQQ Stakes, but Data Lags Market Moves
Recent SEC filings reveal two wealth managers raised their stakes in the Invesco QQQ ETF in Q3 2025, though subsequent data shows one trimmed its position by year-end. The Nasdaq-100 tracker traded near $593, down 1.1%, as investors weigh growth prospects against macro risks.
Servier Acquires Day One Biopharmaceuticals in $2.5 Billion Oncology Deal
French pharmaceutical firm Servier will acquire Day One Biopharmaceuticals for $2.5 billion, gaining the pediatric glioma treatment Ojemda. The deal offers a 68% premium to Day One's recent closing price.
